OUTRAGED HUMAN on Injecting Freedom by Aaron Siri

[OUTRAGED HUMAN]

https://zenodo.org/records/5517264 Green Nanotechnology Innovations to Realize UN Sustainable Development Goals 2030

It is argued that nanotechnology that is considered a technology of the 21st century can be used to realize thirteen out of seventeen Sustainable Development Goals by 2030.

It is argued through predictive analysis that green nanotechnology is safe and secured for the environment and suitable & effective technology and has the ability to help to realize thirteen out of seventeen sustainable development (SD) goals of the United Nations within the planned timeframe of 2030.

TOXICTY? Adverse effects? Deaths? Nah...

Maddie De Garay is only one of these victims. Here are more VAERS IDs (these reported and published): https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=SYM&EVENTS=ON&VAX=COVID19

FLUORESCENT QUANTUM DOTS "PCR TEST" https://www.sec.gov/Archives/edgar/data/1403570/000149315221010243/form10-q.htm#V_009 Major Market Segments

Life Sciences. The life sciences industry was one of the early areas of adoption of QD technology, especially for QDs used in fluorescent markers in diagnostic applications. This includes both the in vitro use of QDs for marking (illuminating) particular cell types or metabolic processes for understanding diseases, and in vivo imaging made possible by QD fluorescence in near infrared that can be detected in deep tissues. The fluorescent qualities of QDs provide an attractive alternative to traditional organic dyes in bio-imaging. It is estimated that QDs are 20 times brighter and 100 times more stable than standard fluorescent indicators. QD technology is also being used in place of colloidal gold nanoparticles in lateral flow test kits such as those used in the rapid Covid 19 antigen test. QDs have been reported in literature to exponential improve the sensitivity of these test enabling earlier detection.

The Federal Drug Administration (“FDA”) has issued emergency use authorization (“EUA”) for medical tests that diagnose Covid-19. The FDA is responsible for protecting the public health by ensuring safety, efficacy, and security of all human and veterinary drugs, biological products, and medical devices. With regards to medical tests, the FDA usually does this by making manufacturers meet rigorous guidelines in an approval process that can take many months. During an emergency, such as a pandemic, it may not be possible to have all the evidence that the FDA would usually have before approving a medical test. If there’s evidence that strongly suggests that patients have benefited from a test, the agency can issue an EUA to make it available. One of the minimum requirements for granting EUA is that the known and potential benefits of the test outweigh the known potential risks. However, this is a minimum requirement and not the standard. The minimum standard can be met and EUA is still not given; there may be additional requirements, such as the test meeting reasonable thresholds for safety and effectiveness and/or people in urgent need of care based on a diagnosis. EUAs are only given during a declared emergency; outside of this, an EUA is never given.

Once the pandemic is over and should FDA EUA of Covid-19 tests be revoked. The 510K approval process which requires validation and submission of the test for FDA 510(k) clearance, which is one of the normally used medical device regulatory pathways for FDA approval would be required to continue to sell the test kits in the USA.

https://blockchainmagazine.net/us-firm-integrates-nanotechnology-blockchain-for-covid-19-immunity-passports/